Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,810 | 61,990 | 49,220 | 7,340 | 11,430 |
| Marketable Securities | 510 | 470 | 490 | 3,600 | 13,390 |
| Receivables | 4,300 | 2,450 | 4,520 | 8,850 | 10,030 |
| Inventories | 3,580 | 3,670 | 3,380 | 4,160 | 4,910 |
| Other current assets | 5,550 | 4,890 | 4,110 | 2,380 | 3,080 |
| TOTAL | $70,750 | $73,470 | $61,720 | $26,330 | $42,840 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 40,290 | 39,200 | 39,920 | 38,900 | 44,440 |
| TOTAL | $40,290 | $39,200 | $39,920 | $38,900 | $44,440 |
| Total Assets | $117,440 | $119,030 | $108,340 | $72,550 | $95,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 40 | 40 | 50 | 450 |
| Accounts payable and accrued liabilities | 14,360 | 14,490 | 10,250 | 15,280 | 20,170 |
| Accrued Expenses | 0 | 0 | 3,430 | 0 | 0 |
| Other current liabilities | 11,840 | 10,730 | 7,630 | 2,260 | 3,420 |
| TOTAL | $27,050 | $26,030 | $22,170 | $17,610 | $24,040 |
| Non-Current Liabilities | |||||
| Long Term Debt | 150 | 140 | 170 | 0 | 0 |
| Other Non-Current Liabilities | 10,120 | 9,400 | 10,090 | 9,580 | 10,570 |
| TOTAL | $87,000 | $85,130 | $64,690 | $14,080 | $13,680 |
| Total Liabilities | $114,070 | $111,180 | $86,860 | $31,700 | $37,730 |
| Shareholders' Equity | |||||
| Common Shares | 37,430 | 30,560 | 30,560 | 30,560 | 30,560 |
| Retained earnings | -128,280 | -115,200 | -102,810 | -88,320 | -74,440 |
| Other shareholders' equity | 94,210 | 12,770 | 93,720 | 19,060 | 22,250 |
| TOTAL | $3,360 | $7,850 | $21,470 | $40,850 | $57,810 |
| Total Liabilities And Equity | $117,430 | $119,030 | $108,330 | $72,550 | $95,540 |